Rockwell Medical to Release First Quarter 2025 Results on Monday, May 12, 2025
Rockwell Medical (Nasdaq: RMTI), a global healthcare company specializing in hemodialysis products, has scheduled its first quarter 2025 financial results release for Monday, May 12, 2025. The company will issue a press release at 6:00am ET, followed by a live conference call and webcast at 8:00am ET.
The earnings call will feature President and CEO Mark Strobeck, Ph.D., and SVP, CFO Jesse Neri, who will discuss Q1 2025 financial and operational results, followed by a Q&A session. Investors can access the call via phone at (888) 660-6347 (US) or 1 (929) 201-6594 (International) using Conference ID 4944610, or through the webcast at www.RockwellMed.com/Results.
Rockwell Medical (Nasdaq: RMTI), un'azienda globale nel settore sanitario specializzata in prodotti per emodialisi, ha programmato la pubblicazione dei risultati finanziari del primo trimestre 2025 per lunedì 12 maggio 2025. L'azienda rilascerà un comunicato stampa alle 6:00 ET, seguito da una conferenza telefonica e una diretta web alle 8:00 ET.
La chiamata sugli utili vedrà la partecipazione del Presidente e CEO Mark Strobeck, Ph.D., e del SVP, CFO Jesse Neri, che discuteranno i risultati finanziari e operativi del Q1 2025, seguiti da una sessione di domande e risposte. Gli investitori possono accedere alla chiamata tramite telefono al (888) 660-6347 (USA) o 1 (929) 201-6594 (Internazionale) utilizzando l'ID Conferenza 4944610, o tramite la diretta web su www.RockwellMed.com/Results.
Rockwell Medical (Nasdaq: RMTI), una empresa de atención médica global especializada en productos para hemodiálisis, ha programado la publicación de sus resultados financieros del primer trimestre de 2025 para el lunes 12 de mayo de 2025. La empresa emitirá un comunicado de prensa a las 6:00 a.m. ET, seguido de una conferencia telefónica en vivo y una transmisión web a las 8:00 a.m. ET.
La llamada sobre ganancias contará con la participación del Presidente y CEO Mark Strobeck, Ph.D., y del SVP, CFO Jesse Neri, quienes discutirán los resultados financieros y operativos del Q1 2025, seguidos de una sesión de preguntas y respuestas. Los inversores pueden acceder a la llamada por teléfono al (888) 660-6347 (EE. UU.) o 1 (929) 201-6594 (Internacional) utilizando el ID de Conferencia 4944610, o a través de la transmisión web en www.RockwellMed.com/Results.
록웰 메디컬 (Nasdaq: RMTI), 혈액 투석 제품을 전문으로 하는 글로벌 헬스케어 회사가 2025년 1분기 재무 결과 발표를 2025년 5월 12일 월요일로 예정했습니다. 회사는 동부 표준시 기준 오전 6시에 보도 자료를 발표하고, 오전 8시에 라이브 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다.
수익 전화 회의에는 사장 겸 CEO인 Mark Strobeck, Ph.D.와 SVP, CFO인 Jesse Neri가 참석하여 2025년 1분기 재무 및 운영 결과에 대해 논의하며, 이후 질의응답 세션이 이어질 것입니다. 투자자들은 전화로 (888) 660-6347 (미국) 또는 1 (929) 201-6594 (국제)로 접속하여 회의 ID 4944610을 사용하거나 www.RockwellMed.com/Results의 웹캐스트를 통해 참여할 수 있습니다.
Rockwell Medical (Nasdaq: RMTI), une entreprise mondiale de soins de santé spécialisée dans les produits d'hémodialyse, a prévu la publication de ses résultats financiers du premier trimestre 2025 pour le lundi 12 mai 2025. L'entreprise publiera un communiqué de presse à 6h00 ET, suivi d'une conférence téléphonique en direct et d'un webinaire à 8h00 ET.
La conférence sur les résultats mettra en vedette le Président et CEO Mark Strobeck, Ph.D., ainsi que le SVP, CFO Jesse Neri, qui discuteront des résultats financiers et opérationnels du Q1 2025, suivis d'une session de questions-réponses. Les investisseurs peuvent accéder à l'appel par téléphone au (888) 660-6347 (États-Unis) ou au 1 (929) 201-6594 (International) en utilisant l'ID de conférence 4944610, ou via le webinaire à www.RockwellMed.com/Results.
Rockwell Medical (Nasdaq: RMTI), ein globales Gesundheitsunternehmen, das sich auf Produkte für die Hämodialyse spezialisiert hat, hat die Veröffentlichung seiner finanziellen Ergebnisse für das erste Quartal 2025 auf Montag, den 12. Mai 2025 terminiert. Das Unternehmen wird um 6:00 Uhr ET eine Pressemitteilung herausgeben, gefolgt von einer Live-Konferenzschaltung und einem Webcast um 8:00 Uhr ET.
Der Gewinnaufruf wird von Präsident und CEO Mark Strobeck, Ph.D., sowie SVP, CFO Jesse Neri geleitet, die die finanziellen und operativen Ergebnisse des Q1 2025 besprechen werden, gefolgt von einer Frage- und Antwortsitzung. Investoren können den Anruf telefonisch unter (888) 660-6347 (USA) oder 1 (929) 201-6594 (International) mit der Konferenz-ID 4944610 oder über den Webcast unter www.RockwellMed.com/Results erreichen.
- None.
- None.
CONFERENCE CALL AND WEBCAST DETAILS
Date: Monday, May 12, 2025
Time: 8:00am ET
Live Number: (888) 660-6347 // (International) 1 (929) 201-6594
Conference Call ID: 4944610
Webcast and Replay: www.RockwellMed.com/Results
Speakers:
- Mark Strobeck, Ph.D. — President and Chief Executive Officer; and
- Jesse Neri — SVP, Chief Financial Officer
Format: Discussion of first quarter 2025 financial and operational results followed by Q&A.
About Rockwell Medical
Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics and the patients they serve with the highest quality products supported by the best customer service in the industry. Rockwell is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people, enabling the Company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients. Hemodialysis is the most common form of end-stage kidney disease treatment and is typically performed at freestanding outpatient dialysis centers, hospital-based outpatient centers, skilled nursing facilities, or in a patient’s home. Rockwell Medical's products are vital to vulnerable patients with end-stage kidney disease, and the Company is relentless in providing unmatched reliability and customer service. Certified as a Great Place to Work® in 2023, 2024 and 2025, and named Fortune Best Workplaces in Manufacturing & ProductionTM in 2024, Rockwell Medical is Driven to Deliver Life-Sustaining Dialysis SolutionsTM. For more information, visit www.rockwellmed.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250414889038/en/
Heather R. Hunter
SVP, Chief Corporate Affairs Officer
(248) 432-1362
IR@RockwellMed.com
Source: Rockwell Medical
FAQ
When will Rockwell Medical (RMTI) release Q1 2025 earnings?
How can investors access RMTI's Q1 2025 earnings call?
Who will be presenting at Rockwell Medical's Q1 2025 earnings call?
What is Rockwell Medical's (RMTI) main business focus?
